These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6359036)

  • 1. [Immunocytochemical method for the determination of progesterone receptors in breast cancer].
    Caruso F; Papotti M; Di Saverio G; Mignani S; Scarani P
    Pathologica; 1983; 75(1037):313-23. PubMed ID: 6359036
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of cytoplasmic estrogen and progesterone receptors in breast carcinoma: comparison of a histochemical and a radiometric method].
    Wolf D; Forti E; Gion M; Melia M; Dittadi R; Mione R
    Pathologica; 1985; 77(1049):305-9. PubMed ID: 3831881
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormone receptors of human breast cancer. I. Determination of estrogen and progesterone receptors in human breast cancer].
    Zhang HY
    Zhonghua Zhong Liu Za Zhi; 1983 May; 5(3):168-71. PubMed ID: 6628170
    [No Abstract]   [Full Text] [Related]  

  • 4. [Follow-up of patients with receptor state determined by radiometric and histochemical methods].
    De Giuli P; Gubetta L
    Pathologica; 1985; 77(1049):311-4. PubMed ID: 3008070
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progesterone receptors in breast cancer (author's transl)].
    Navarro Moreno MA; Pastor Ferrer MC; Carrera Font T; Planells Torres P; Bonnin Lafuente R; Rosel Soria P
    Med Clin (Barc); 1981 Sep; 77(4):158-61. PubMed ID: 7198174
    [No Abstract]   [Full Text] [Related]  

  • 6. The incidence of positive oestrogen and progesterone receptors in breast cancer of Greek women.
    Vassilaros S; Adamopoulos DA; Papadiamantis J; Dessypris A; Kapolla N
    Anticancer Res; 1981; 1(4):195-7. PubMed ID: 7345966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical determination of estrogen and progesterone receptors and flow cytometric DNA analysis of breast cancer on fine needle aspirates.
    Marrazzo A; Russo A; Bazan V; Taormina P; Lupo F; Bazan P
    Anticancer Res; 1993; 13(6B):2435-40. PubMed ID: 8135480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
    Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
    Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Demonstration of estradiol and progesterone receptors in histological preparations].
    Fetissof F; Lansac J; Arbeille-Brassart B
    Ann Anat Pathol (Paris); 1980; 25(3):201-16. PubMed ID: 7015929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between morphology and steroid receptors in breast cancer].
    Hanselmann R; Genton CY
    Pathologe; 1983 Jan; 4(1):17-23. PubMed ID: 6844281
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hormonal receptors and breast cancer. Results on 589 patients].
    Bonneterre J; Peyrat JP; Vandewalle B; Vennin P; Beuscart R; Lefebvre J; Demaille A
    LARC Med; 1984 Oct; 4(8):467-72. PubMed ID: 6096652
    [No Abstract]   [Full Text] [Related]  

  • 12. Histochemical determination of estrogen and progesterone binding in fine needle aspirates of breast cancer. Correlation with conventional biochemical assays.
    Curtin CT; Pertschuk LP; Mitchell V
    Acta Cytol; 1982; 26(6):841-6. PubMed ID: 6961721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of cytosolic receptors for estradiol and progesterone in 137 cases of breast cancer: technics, clinical and histopathological correlations].
    Dewailly D; Bonneterre J; Vandewalle B; Delobelle A; Lefebvre J; Demaille AC
    Lille Med; 1980 Nov; 25(9):496-501. PubMed ID: 7453486
    [No Abstract]   [Full Text] [Related]  

  • 14. [Quantitative determination of steroid hormone receptors in breast cancer tissue outside tumor centers].
    Prechtel D; Prechtel K
    Pathologe; 1993 Jan; 14(1):16-20. PubMed ID: 8451222
    [No Abstract]   [Full Text] [Related]  

  • 15. [Content of 17 beta éstradiol, progesterone and glucocorticoid receptors in patients with benign breast diseases].
    Bassalyk LS; Kuz'mina ZV; Murav'eva NI; Smirnova KD; Vishniakova VV
    Vopr Onkol; 1982; 28(7):3-6. PubMed ID: 7101825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestin receptor assay in fine needle aspiration biopsies of breast tumors.
    Magdelenat H; Laine-Bidron C; Merle S; Zajdela A
    Bull Cancer; 1984; 71(1):74-5. PubMed ID: 6713116
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy.
    Fernandez MD; Alaghband-Zadeh J; Burn JI
    Clin Oncol; 1983 Sep; 9(3):245-50. PubMed ID: 6616999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal receptors and response to treatment of breast cancer: a retrospective evaluation in 60 patients.
    Loven D; Rakowsky E; Stein JA; Geier A; Lunenfeld B
    Isr J Med Sci; 1981; 17(9-10):960-4. PubMed ID: 7309485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and progesterone receptors in breast cancer: a new approach to measure.
    Lee SH
    Conn Med; 1980 Oct; 44(10):622-5. PubMed ID: 7226762
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunocytochemical analysis of the estrogen receptors in a case of breast phyllodes tumor.
    Bondi A; Ghidoni D; De Maurizi M
    Pathologica; 1983; 75(1037):443-5. PubMed ID: 6316238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.